Actos

What Is Actos?

Actos (Generic name: pioglitazone hydrochloride) is a Type 2 diabetes drug often used with a diet and exercise program. It is also marketed in the U.S. as Actoplus Met and Duetact. Actos is often prescribed as an alternative diabetic medication to Avandia, which has an increased risk of cardiac events. Actos medication was the ninth best selling drug in the U.S. in 2010.

Actos Side Effects

Actos medication is one of the most popular diabetes drugs in the world. Originally, Actos was scrutinized for being associated with an increased risk of heart congestion, much like the similar drug Avandia. Recently, however, studies have shown that extended use of Actos is linked to bladder cancer. These studies show that the longer one takes Actos, the greater the risk of developing bladder cancer.

Signs of bladder cancer include blood or red color in your urine, urgent need to urinate or pain while urinating, as well as a frequent need to urinate.

If you have experienced any of these dangerous side effects while taking Actos, Actoplus Met, Actoplus met XR, or Duetact you may be entitled to compensation.

Generic Actos

Actos is manufactured by Takeda Pharmaceuticals and is currently under the protection of patents that prevent any generic versions of Actos medication from being manufactured in the United States. However, an Internet search will pull up many generic versions of Actos medication that may be fake or even more dangerous than Actos. You should not buy any generic Actos until there is an approved generic available in August of 2012.

FDA's Role In Actos

In September of 2010, the FDA announced that Takeda Pharmaceuticals, the manufacturer of Actos, supplied provisional data after five years that suggests there may be a risk of bladder cancer from Actos side effects the longer the medication is used. After two years, the rate of exposure and the increased risk of bladder cancer reached statistical significance.

As a result of this mounting scientific evidence, the FDA has issued warnings regarding Actos and bladder cancer. In France, the French Agency for Safety of Health Products recalled Actos from the market on June 9, 2011. Regulators in Germany have recommended not starting new patients on Actos.

The FDA has issued warnings, requesting doctors to weigh the value of the drug for diabetic control against the associated dangers to heart and bladder health. They have not, however, required Takeda Pharmaceuticals to remove the drug from the market. The FDA will continue to evaluate data from the ongoing 10-year epidemiological study. The Agency will also conduct a comprehensive review of the results from the French study. The FDA will update the public when more information becomes available. http://www.fda.gov/Drugs/DrugSafety/ucm259150.htm

Contact Our Office in Southern California

For patients there remains the possibility of recovering damages though an Actos lawsuit. Representation from an attorney may be the only way those negatively affected by the drug may be able to be compensated for damages. The attorneys at Vititoe Law Group have many years of experience with dealing with the largest pharmaceutical companies.

For more information, call Vititoe Law Group at 818-851-1886.

If you or someone you love has already been exposed to the danger and increased risk of bladder cancer due to Actos medication, you deserve monetary compensation for your injuries, and it is your duty as a consumer to hold the negligent company responsible. If you feel you might have suffered damage as a consequence of taking Actos, quickly fill out the form or give us a call today for a free consultation.

Attorney Referrals: If you are an attorney concerned about the harm Actos has done to a client, we invite you to contact our firm today.

This website is not affiliated in any way with Actos®. Actos® is a registered trademark of Takeda Pharmaceuticals. Before starting or stopping any medication, it is always wise to consult a doctor.